As pharmaceutical industry retreats, research and development for tuberculosis treatments, diagnostics and prevention relies more than ever on government support, and it’s dropping, Treatment Action Group report shows . . . LIVERPOOL, England – The chance to have the right people and the right information in the right place at the same time comes all too rarely […]
LIVERPOOL, England – While much of the focus at this conference focuses on the pursuit of new knowledge, to better treat, diagnose and prevent tuberculosis, a group of experts from leading institutions worldwide have put together everything they currently know about the disease in 23 pages. Among the points, lead author Madhukar Pai said today, as […]
HIV
The U.S. Department of State today issued an expression of concern over Tanzanian government actions targeting its LGBT population, noting that the violence, oppression and intimidation […]
Tuberculosis
THE HAGUE, Netherlands – New results from the ongoing Nix-TB trial continue to confirm a short-course treatment regimen of bedaquiline – one of the two newest […]
Research & Development
A trial to test the safety of, and immune response prompted by, the latest candidate for a vaccine to protect against Zika virus infection has begun […]
Policy
Two years after launching surveillance of acute flaccid myelitis, and amid climbing cases, CDC continues to seek cause, and notes gaps in knowledge of long term […]